CTRI/2021/01/030793已完成3 期
A Multi-centric, Comparative, Randomized, Double-blind, Placebo-controlled, Proof of concept trial to evaluate the Efficacy and Safety of Intravenous Glutathione, as an add-on to the ââ?¬Å?Standard of Careââ?¬? in Moderate COVID-19 Pneumonia Patients.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with laboratory confirmation of infection with SARS-CoV-2 by positive RT-PCR.
- •2. Patients with moderate COVID-19 (According to Clinical Management Protocol: COVID 19, Govt. of India).
- •-Patients with presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94% (range 90-94%) on room air
- •-Respiratory Rate ââ?°Â¥24 per minute
- •-Pneumonia with no signs of severe disease
- •3. Symptomatic adult male or non-pregnant female (ââ?°Â¥18 years)
- •4. Voluntarily participating in the clinical study and patients or legal representative willing to sign informed consent.
排除标准
- •1. Asymptomatic COVID-19 patients.
- •2. Patients with known hypersensitivity to glutathione or related drugs.
- •3. Patients enrolled in any other investigational drug studies in COVID-19.
- •4. Severe infection and need for invasive or non-invasive ventilator support.
- •5. Pregnant or lactating women
研究者
相似试验
已完成
3 期
A clinical trial of Intravenous Aviptadil along with standard treatment in severe COVID-19 Patients with respiratory failure.CTRI/2021/04/033118Zuventus Healthcare Limited150
尚未招募
3 期
postoperative paiCTRI/2019/02/017850Akums Drugs Pharmaceutical Ltd India
已完成
2 期
Study the safety and efficacy of PMZ-2010 in patients with shock due to blood loss.CTRI/2017/03/008184Pharmazz India Private Limited50
尚未招募
不适用
A Clinical study to evaluate the Safety and Efficacy of CurQfen in mild to moderate Knee Osteoarthritis Patients.CTRI/2019/03/017954Akay Flavours and Aromatics Private Limited
已完成
3 期
Effect of PMZ-2010 in Hypovolemic Shock patients.CTRI/2019/01/017196Pharmazz India Private Limited105